Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGP weight loss injections — primarily Mounjaro (tirzepatide) and Wegovy (semaglutide) — are prescription-only medicines that a GP or another qualified prescriber can legally supply following a clinical assessment. Both are licensed in the UK for adults with a BMI of 30 or above, or from 27 with a weight-related health condition. These are regulated weight-loss injections, not over-the-counter treatments, and a prescriber decides suitability based on your full medical picture. If you have been searching for a route to these medicines and feel frustrated by how complicated it all seems, that is a reasonable reaction, the NHS pathway, private pharmacy route, and GP involvement each work differently, and understanding the differences makes the whole process easier to navigate.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A GP's role in prescribing weight loss injections from a GP is the same as any prescriber's: they assess whether the medicine is clinically appropriate for you specifically. That means reviewing your BMI, any existing health conditions, your current medicines, and whether there are contraindications, such as a personal or family history of medullary thyroid cancer, a history of pancreatitis, or certain gastrointestinal conditions. They will also discuss realistic expectations. Neither Mounjaro nor Wegovy is assessed for quick or cosmetic weight loss; the MHRA's published guidance on GLP-1 medicines makes this point explicitly.
If your GP decides the treatment is suitable, they write a prescription. On the NHS, that prescription is dispensed under the terms of whichever commissioning arrangement your area operates. In a private setting, you pay separately for the consultation, prescription, and medicine. One thing worth knowing: a GP does not have to prescribe these medicines, and many practices have not yet opted into the NHS tirzepatide pathway that opened to primary care in April 2026. So a referral to a weight management service, or a private route, may still be the practical answer even where a GP is supportive.
The clinical assessment itself (checking your weight, your history, your suitability) is what makes a prescription legal and safe. Whether a GP can give weight loss injections depends on their service setup, not just their willingness.
The NHS pathway for these medicines is currently rationed by strict eligibility criteria, rolled out in phases. From June 2025, tirzepatide (Mounjaro) became available on the NHS to adults with a BMI of 40 or above who have four or more of five specified weight-related conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. A second cohort (BMI 35 to 39.9 with four or more of those conditions) opened in late June 2026. NICE's recommendation for tirzepatide (TA1026) sets out these thresholds in full, including the lower BMI cut-offs that apply for some ethnic backgrounds under UK guidance.
Wegovy (semaglutide) on the NHS requires referral to a specialist weight management service and carries a two-year maximum treatment duration under NICE's appraisal (TA875). Waiting lists for those services are commonly long. If you meet neither set of NHS criteria, or you do not want to wait, a private prescription is the lawful alternative, subject to a clinical assessment confirming you meet the licensed criteria. You can read about getting weight loss injections without a GP referral if you want to understand the private route in detail.
Lower BMI thresholds apply for certain ethnic backgrounds across both medicines and both pathways; the adjustment is 2.5 kg/m² under UK guidance. BMI alone is never the whole picture, the prescriber weighs up all of it.
The most common side effects of both Mounjaro and Wegovy are gastrointestinal. Patients frequently report nausea, loose stools, constipation, indigestion, or burping, particularly during the early weeks or following a dose increase. Fatigue and headache are also reported. The NHS tirzepatide medicines page lists these in plain language alongside guidance on when to seek help.
Most GI symptoms settle within a couple of weeks as your body adjusts. Keeping well hydrated matters, especially if nausea reduces your appetite for fluids. Eating smaller, lower-fat meals at the start can help too, though specific advice should come from your prescriber rather than general reading.
There are rarer but serious effects to be aware of. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but potentially serious side effect of GLP-1 medicines: severe, persistent stomach pain (particularly if it radiates to the back, with or without vomiting) warrants urgent medical attention. Gallbladder symptoms, signs of dehydration from prolonged vomiting or diarrhoea, and allergic reactions are other reasons to get medical help promptly rather than waiting for a scheduled review. Suspected side effects can be reported via the MHRA Yellow Card scheme. Your Patient Information Leaflet remains the authoritative reference for the full side-effect profile of whichever medicine you are prescribed.
The practical difference between a private online prescriber and a GP comes down to speed, eligibility thresholds, and what the service includes. A GPhC-registered online pharmacy can assess you the same day and, where clinically suitable, dispatch your medicine that day for next-working-day delivery. GP access depends on whether your practice has opted into the relevant NHS contract and whether you meet the NHS eligibility criteria, which are considerably narrower than the licensed thresholds.
Private treatment costs more than an NHS prescription, but it is inclusive of things that are often charged separately elsewhere: consultation, clinical review, the prescription itself, delivery, and ongoing aftercare support. If you are based locally, our page covering weight loss injections in Benfleet explains what to expect from a nearby private service. Cost considerations are real, and if you are weighing up your options it is also worth reading about the three weight loss injections currently available so you understand how Mounjaro, Wegovy, and their alternatives compare before committing to a route.
Any legitimate private provider should be verifiable on the GPhC register at pharmacyregulation.org. That check takes under a minute and is worth doing before submitting any consultation. Red flags include sellers offering these medicines without a clinical assessment, or prices that sit well below the market range without explanation.
Our clinical team at nume (reviewed by a GPhC-registered Independent Prescriber) assesses every consultation personally. If you have questions ahead of starting, our FAQs page covers the most common ones.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.